The Absorption, Metabolism and Excretion of [14C]Ensartinib in Human
Status:
Unknown status
Trial end date:
2019-10-01
Target enrollment:
Participant gender:
Summary
This is a single-center, open-label, single-dose phase I study to investigate the absorption,
metabolism and excretion of [14C] Ensartinib in healthy Chinese male subjects. The study will
be conducted into two steps：Firstly, 2 subjects are enrolled in to participate in the pilot
study to grope for the completion date of plasma, urine and feces sampling on the 3rd day
post-dose and onwards. Then, the collection time of blood and excreta samples (urine and
feces) from the subsequent 4-6 subjects will be adjusted according to the pilot study.